Unknown

Dataset Information

0

Editorial: Arthritis Gene Therapy Using Interleukin-1 Receptor Antagonist.

ABSTRACT:

SUBMITTER: Evans C 

PROVIDER: S-EPMC6203597 | biostudies-literature | 2018 Nov

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Editorial: Arthritis Gene Therapy Using Interleukin-1 Receptor Antagonist.

Evans Christopher C  

Arthritis & rheumatology (Hoboken, N.J.) 20181101 11

Similar Datasets

Unknown A peptoid interleukin‐15 receptor antagonist suppresses inflammation and arthritis in mice
| S-EPMC9686008 | biostudies-literature
Unknown Anti-Inflammatory Therapy for Temporomandibular Joint Osteoarthritis Using mRNA Medicine Encoding Interleukin-1 Receptor Antagonist.
| S-EPMC9505648 | biostudies-literature
Unknown The Clinical Significance of Interleukin-1 Receptor Antagonist +2018 Polymorphism in Rheumatoid Arthritis.
| S-EPMC4841519 | biostudies-literature
Unknown IL1RN Variation Influences Both Disease Susceptibility and Response to Recombinant Human Interleukin-1 Receptor Antagonist Therapy in Systemic Juvenile Idiopathic Arthritis.
| S-EPMC6105455 | biostudies-literature
Unknown Arterial inflammation in mice lacking the interleukin 1 receptor antagonist gene.
| S-EPMC2195758 | biostudies-literature
Unknown Toxoplasma gondii infection inhibits Th17-mediated spontaneous development of arthritis in interleukin-1 receptor antagonist-deficient mice.
| S-EPMC3318428 | biostudies-literature
Unknown Deficiency of Interleukin-1 Receptor Antagonist: A Case with Late Onset Severe Inflammatory Arthritis, Nail Psoriasis with Onychomycosis and Well Responsive to Adalimumab Therapy.
| S-EPMC6699325 | biostudies-literature
Unknown Mortality Benefit of Recombinant Human Interleukin-1 Receptor Antagonist for Sepsis Varies by Initial Interleukin-1 Receptor Antagonist Plasma Concentration.
| S-EPMC5734955 | biostudies-literature
Unknown Association of Interleukin-1 Beta and Interleukin-1 Receptor Antagonist Gene Polymorphisms and Plasma Levels with Diabetic Nephropathy.
| S-EPMC9159863 | biostudies-literature
Unknown Cytochrome P450 activity in rheumatoid arthritis patients during continuous IL-6 receptor antagonist therapy.
| S-EPMC10663184 | biostudies-literature